• Mon, February 5, 2024
Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $29 on, Feb 5th, 2024
Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $24 to $29 on, Feb 5th, 2024.
Mayank has made no other calls on TGTX in the last 4 months.
There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mayank
- Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 11th, 2024
- Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $23 on, Wednesday, November 1st, 2023
- Matthew Andrews of "Jefferies" Maintained at Strong Buy on, Wednesday, November 1st, 2023
Like: 👍
